In Global News: Singing With Donated Lungs, the PURE Study Reports, and Congenital Aortic Stenosis [1]
Patient Care
An opera singer talks about receiving a double-lung transplant [3].
A team at the American University of Beirut Medical Center in Lebanon performs the first transcaval percutaneous aortic valve replacement [4] in the region.
A woman who received a transplanted heart in 2013 will run the Chicago Marathon [5] on Sunday with her donor’s father.
Drugs and Devices
BioStable Science & Engineering, Inc. announced the first commercial use of its HAART 200 Aortic Annuloplasty Device [6], which has been cleared by the US FDA to facilitate bicuspid aortic valve repair.
Research, Trials, and Funding
Researchers in Ohio, US, find that balloon aortic valvuloplasty is a successful intervention for 70% [7] of patients with noncritical congenital aortic stenosis. Is a 70% success rate good enough [8]?
The second report from the Prospective Urban Rural Epidemiology (PURE) study, an observational study of over 130,000 people from many different countries, finds a positive association between activity level [9] and lowered risk of cardiovascular disease. The conclusions from the first PURE report questioned the current views of carbohydrates and fats in a healthful diet [10].
Researchers at Gentofte Hospital in Denmark find that infective endocarditis developed [11] in 2.5% of patients with end-stage renal disease.
A study from researchers at the University of Texas at Arlington in the US finds that zinc interferes with overactive calcium signaling to specifically impede cancerous esophageal cell growth [12] in culture.